These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Deletion of the ORF2 gene of the neuropathogenic equine herpesvirus type 1 strain Ab4 reduces virulence while maintaining strong immunogenicity. Schnabel CL; Wimer CL; Perkins G; Babasyan S; Freer H; Watts C; Rollins A; Osterrieder N; Wagner B BMC Vet Res; 2018 Aug; 14(1):245. PubMed ID: 30134896 [TBL] [Abstract][Full Text] [Related]
7. Immune horses rapidly increase antileukoproteinase and lack type I interferon secretion during mucosal innate immune responses against equine herpesvirus type 1. Holmes CM; Babasyan S; Eady N; Schnabel CL; Wagner B Microbiol Spectr; 2024 Oct; 12(10):e0109224. PubMed ID: 39162558 [TBL] [Abstract][Full Text] [Related]
8. Cell-mediated immunity evaluation in foals infected with virulent equine herpesvirus-1 by multi-parameter flow cytometry. Platt R; Sponseller BA; Chiang YW; Roth JA Vet Immunol Immunopathol; 2010 Jun; 135(3-4):275-81. PubMed ID: 20116862 [TBL] [Abstract][Full Text] [Related]
9. Identification and characterization of equine herpesvirus type 1 pUL56 and its role in virus-induced downregulation of major histocompatibility complex class I. Ma G; Feineis S; Osterrieder N; Van de Walle GR J Virol; 2012 Apr; 86(7):3554-63. PubMed ID: 22278226 [TBL] [Abstract][Full Text] [Related]
10. The deletion of the ORF1 and ORF71 genes reduces virulence of the neuropathogenic EHV-1 strain Ab4 without compromising host immunity in horses. Wimer CL; Schnabel CL; Perkins G; Babasyan S; Freer H; Stout AE; Rollins A; Osterrieder N; Goodman LB; Glaser A; Wagner B PLoS One; 2018; 13(11):e0206679. PubMed ID: 30440016 [TBL] [Abstract][Full Text] [Related]
11. Infection of peripheral blood mononuclear cells with neuropathogenic equine herpesvirus type-1 strain Ab4 reveals intact interferon-α induction and induces suppression of anti-inflammatory interleukin-10 responses in comparison to other viral strains. Wagner B; Wimer C; Freer H; Osterrieder N; Erb HN Vet Immunol Immunopathol; 2011 Sep; 143(1-2):116-24. PubMed ID: 21764140 [TBL] [Abstract][Full Text] [Related]
12. Cytokine responses to EHV-1 infection in immune and non-immune ponies. Coombs DK; Patton T; Kohler AK; Soboll G; Breathnach C; Townsend HG; Lunn DP Vet Immunol Immunopathol; 2006 May; 111(1-2):109-16. PubMed ID: 16473413 [TBL] [Abstract][Full Text] [Related]
13. Evaluation of immune responses following infection of ponies with an EHV-1 ORF1/2 deletion mutant. Soboll Hussey G; Hussey SB; Wagner B; Horohov DW; Van de Walle GR; Osterrieder N; Goehring LS; Rao S; Lunn DP Vet Res; 2011 Feb; 42(1):23. PubMed ID: 21314906 [TBL] [Abstract][Full Text] [Related]
14. Equine Herpesvirus 1 Multiply Inserted Transmembrane Protein pUL43 Cooperates with pUL56 in Downregulation of Cell Surface Major Histocompatibility Complex Class I. Huang T; Ma G; Osterrieder N J Virol; 2015 Jun; 89(12):6251-63. PubMed ID: 25833055 [TBL] [Abstract][Full Text] [Related]
16. Expression of late viral proteins is restricted in nasal mucosal leucocytes but not in epithelial cells during early-stage equine herpes virus-1 infection. Gryspeerdt AC; Vandekerckhove AP; Baghi HB; Van de Walle GR; Nauwynck HJ Vet J; 2012 Aug; 193(2):576-8. PubMed ID: 22425309 [TBL] [Abstract][Full Text] [Related]
17. Absence of viral envelope proteins in equine herpesvirus 1-infected blood mononuclear cells during cell-associated viremia. van der Meulen K; Caij B; Pensaert M; Nauwynck H Vet Microbiol; 2006 Mar; 113(3-4):265-73. PubMed ID: 16387454 [TBL] [Abstract][Full Text] [Related]
18. Equine alphaherpesviruses (EHV-1 and EHV-4) differ in their efficiency to infect mononuclear cells during early steps of infection in nasal mucosal explants. Vandekerckhove AP; Glorieux S; Gryspeerdt AC; Steukers L; Van Doorsselaere J; Osterrieder N; Van de Walle GR; Nauwynck HJ Vet Microbiol; 2011 Aug; 152(1-2):21-8. PubMed ID: 21536394 [TBL] [Abstract][Full Text] [Related]
19. Equine Herpesvirus 1 Bridles T Lymphocytes To Reach Its Target Organs. Poelaert KCK; Van Cleemput J; Laval K; Favoreel HW; Couck L; Van den Broeck W; Azab W; Nauwynck HJ J Virol; 2019 Apr; 93(7):. PubMed ID: 30651370 [TBL] [Abstract][Full Text] [Related]
20. Equid Herpesvirus 1 Targets the Sensitization and Induction Steps To Inhibit the Type I Interferon Response in Equine Endothelial Cells. Oladunni FS; Sarkar S; Reedy S; Balasuriya UBR; Horohov DW; Chambers TM J Virol; 2019 Dec; 93(23):. PubMed ID: 31511388 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]